Antiretroviral therapy coverage in Malaysia
Malaysia: Antiretroviral therapy coverage was 60.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Malaysia, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Malaysia recorded 60.0% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.
That represents a change of up 3.4% on the previous year and up 114.3% over ten years.
Over the whole period, antiretroviral therapy coverage in Malaysia peaked at 60.0% in 2024 and was at its lowest, 0.0%, in 2000.
Malaysia ranks 106th of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Malaysia, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 2.0% | — |
| 2002 | 4.0% | +100.0% |
| 2003 | 6.0% | +50.0% |
| 2004 | 8.0% | +33.3% |
| 2005 | 10.0% | +25.0% |
| 2006 | 12.0% | +20.0% |
| 2007 | 14.0% | +16.7% |
| 2008 | 15.0% | +7.1% |
| 2009 | 17.0% | +13.3% |
| 2010 | 18.0% | +5.9% |
| 2011 | 19.0% | +5.6% |
| 2012 | 20.0% | +5.3% |
| 2013 | 23.0% | +15.0% |
| 2014 | 28.0% | +21.7% |
| 2015 | 33.0% | +17.9% |
| 2016 | 45.0% | +36.4% |
| 2017 | 48.0% | +6.7% |
| 2018 | 51.0% | +6.2% |
| 2019 | 54.0% | +5.9% |
| 2020 | 57.0% | +5.6% |
| 2021 | 57.0% | +0.0% |
| 2022 | 56.0% | -1.8% |
| 2023 | 58.0% | +3.6% |
| 2024 | 60.0% | +3.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 8.8% | 0.0% | 17.0% | 10 |
| 2010s | 33.9% | 18.0% | 54.0% | 10 |
| 2020s | 57.6% | 56.0% | 60.0% | 5 |
Countries ranked near Malaysia
- 103 Albania 61.0% compare
- 103 Montenegro 61.0% compare
- 103 Timor-Leste 61.0% compare
- 106 Barbados 60.0% compare
- 106 Bolivia, Plurinational State of 60.0% compare
- 109 North Macedonia 59.0% compare
More health data for Malaysia
- Un projection of annual infant deaths, annual growth rate -0.9119 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2888 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,250 deaths per 1,000 people (2090)
- Number of infants who die before age 1 652 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 18 (2025)
- Population ages 00-04, female, annual growth rate -0.7207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0297 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5991 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Malaysia?
- Antiretroviral therapy coverage in Malaysia was 60.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Malaysia?
- The highest recorded value was 60.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Malaysia?
- The lowest recorded value was 0.0% in 2000.
- How does Malaysia rank for antiretroviral therapy coverage?
- Malaysia ranks 106th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Malaysia?
- Over the last ten years it is up 114.3%. The long-run trend across the full record is volatile.
- Where does this Malaysia data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.